Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11820833
Peptides that inhibit binding of EPCR to its ligand to treat inflammation
granted -
US 11819516
Immunotherapy
granted -
US 11819517
Methods of using tumor infiltrating lymphocytes in double-refractory melanoma
granted -
US 11819523
Compositions and methods for C. difficile treatment
granted -
IT 202200010244
Lacticaseibacillus paracasei DG® CNCM I-1572 DSM 34154 per uso in un metodo di trattamento della disbiosi in pazienti affetti da IBS
granted -
US 11813282
Injectable scaffold for treatment of intracranial aneurysms and related technology
granted -
US 11813335
Pyrrolobenzodiazepine-antibody conjugates
granted -
US 11813341
Dental product with enhanced toughness
granted -
US 11813357
Treatment of hip pain with sustained-release liposomal anesthetic compositions
granted -
US 11813319
Development of a novel live attenuated African Swine Fever vaccine based in the deletion of gene I177L
granted -
US 11813314
Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 11814376
Hepatitis b core protein modulators
granted -
US 11813257
Methods of treating erythropoietic protoporphyria, X-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitors
granted -
US 11814659
Tunable nanoscale cages from self-assembling DNA and protein building blocks
granted -
US 11813320
Genetically engineered foot and mouth disease virus and related proteins, polynucleotides, compositions, methods and systems
granted -
US 11814625
Aptamers as a therapeutic tool to prevent protein aggregation in neurodegenerative disease
granted -
US 11813316
Lentiviral vector for treating hemoglobin disorders
granted -
US 11814657
Modified DNase and uses thereof
granted -
US 11814624
Targeted non-viral DNA insertions
granted -
US 11813123
Ultrasound responsive micro-composite markers
granted -
US 11813267
DNA-PK inhibitors
granted -
US 11814432
Anti-HLA-A2 antibodies, related chimeric antigen receptors, and uses thereof
granted -
US 11813277
Methods and agents for modulating inflammation
granted -
US 11813241
Multi-arm polymeric prodrug conjugates of taxane-based compounds
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.